Growth Capital • Life Science

MCH Private Equity Invests In Agrovin

On November 14, 2022, private equity firm MCH Private Equity invested in life science company Agrovin

Investment Context
  • This is MCH Private Equity’s 2nd transaction in the Life Science sector.
  • This is MCH Private Equity’s 30th transaction in Spain.

Explore All 400 Growth Capital Life Science Deals - Search the Database Free


Investment Summary

Date November 14, 2022
Target Agrovin
Sector Life Science
Investor(s) MCH Private Equity
Deal Type Growth Capital

Target Company

Agrovin

Alcázar de San Juan, Spain
Agrovin is a provider of natural ingredients and technology for the beverage industry, specializing in the manufacturing and distribution of oenological products and machinery with a global presence. Agrovin has been able to develop a complete, diversified and innovative range of products and equipment for clients such as wineries and laboratories, with more than 36 patents at European, Asian and national level. Its products are sold to a customer base of over 3,800 from different industries through a well-known and strongly positioned brand. Agrovin was founded in 1957 and is based in Alcázar de San Juan, Spain.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Investor Overview 1

Investor

MCH Private Equity

Madrid, Spain

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1998
PE ASSETS 1.3B EUR
Size Large
Type Sector Agnostic
DESCRIPTION

MCH Private Equity is a private investment firm focused on mid-sized opportunities in Spain and Portugal. MCH invests in businesses exhibiting growth potential (organic/add-on), ability to improve operating margins, and consistent cash-flows. MCH is a generalist investor, however the Firm has a strong interest in sectors/markets undergoing consolidation. The Firm's target investment size is €15 to €45 million. MCH was formed in 1998 and is based in Madrid.


Deal Context for Investor #
Overall 35 of 38
Sector: Life Science 2 of 3
Type: Growth Capital 6 of 7
Country: Spain 30 of 32
Year: 2022 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-10-05 Llusar

Chilches, Spain

Llusar is dedicated to the production and marketing of premium oranges and mandarins. The company offers the highest level of quality in citrus fruits, grown in privileged locations, guaranteeing their quality, flavour and smoothness. Llusar was founded in 1926 and is based in Chilches, Spain.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-03-03 Fermax

Valencia, Spain

Fermax is a manufacturer of audio and video door entry systems, access control and connectivity solutions for both residential and commercial use. The company's capacity for innovation is focused on residential connectivity and communication in buildings, covering everything from traditional audio intercoms to the most cutting-edge video intercoms, security systems, home automation and access control. Fermax was founded in 1949 and is based in Valencia, Spain.

Buy -

Explore Related M&A Activity